Platelets are circulating, highly differentiated, a nuclear cellular fragments derived from megakaryocytes. One of the tissue-specific features of these cells is their fibrinogen receptor, alphaII/beta3. This integrin receptor is densely packed on the surface of the platelet and plays a key role in platelet aggregation and thrombus formation. This application, a part of the proposed Program Project, will study the biology of this critical receptor, focusing on the regulated expression of the alphaIIb gene and on the analysis of the molecular basis of Glanzmann thrombasthenia. There are three specific aims to this application. I. Defining the Proximal Promoter Elements Regulating alphaIIb Expression. Proposed studies will concentrate on the further analysis of three regions: The first is an Sp1-based negative regulatory region centered at -135bp upstream to the transcriptional start site. We plan to define its local interactions and biological role. We also plan to examine the biological relevance of a potential PU.1-binding site at -510 bp and a potential GATA-1 interacting region between -450 to -350 bp. II. Characterizing Distal Regions of the alphaIIb Gene. Two approaches will be followed to search for such distal regulatory elements: The first will examine the alphaIIb gene locus for tissue-specific, DNase 1 hypersensitive sites (HSS). We have preliminarily defined two such sites 5 and 6 kilobasepairs (kb), respectively, upstream of the human alphaIIb gene. Using available P1 alphaIIb clones, we plan to subclone these regions, sequence them, and characterize them in vitro and also in transgenic mice models. In the second approach, we plan on creating a series of transgenic animals containing various lengths of the human alphaIIb gene locus isolated from lambda, cosmid and P1 clones that will be tested to see what is the minimal construct size required for consistent, high levels of tissue-specific human alphaIIb gene expression in mice. Once such a region is defined, we will focus on Dnase 1 HSS studies to further localize potential distal megakaryocyte-specific regulatory elements and incorporate these regions into further expression constructs. III. Functional Analysis of the alphaIIb/beta3 Receptor. These studies will focus on the analysis of thrombasthenic mutations that have already been published by us or that are under present analysis. These studies will include further analysis of the Ca2+-binding domains of alphaIIb and beta3 in intracellular receptor processing, and analysis of a new alphaIIb variant (P176 to A) and the role of this region of alphaIIb in ligand binding, and a mutation in the C-terminus of alphaIIb (Q819 to P) and the role of the C-terminal alphaIIb heavy chain in receptor processing and activation. These and related studies focus on intracellular processing and ligand binding and should provide important new insights into the biology of this important integrin receptor.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL040387-13
Application #
6302216
Study Section
Project Start
2000-04-01
Project End
2001-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
13
Fiscal Year
2000
Total Cost
$306,320
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Capitano, Maegan; Zhao, Liang; Cooper, Scott et al. (2018) Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-?1 secretion and hematopoiesis in mice. Blood 132:1027-1038
Branchford, B R; Stalker, T J; Law, L et al. (2018) The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. J Thromb Haemost 16:352-363
Zhao, Baobing; Mei, Yang; Cao, Lan et al. (2018) Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms. J Clin Invest 128:125-140
Khandelwal, Sanjay; Ravi, Joann; Rauova, Lubica et al. (2018) Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway. Blood 132:2431-2440
Villa, Carlos H; Pan, Daniel C; Johnston, Ian H et al. (2018) Biocompatible coupling of therapeutic fusion proteins to human erythrocytes. Blood Adv 2:165-176
Ma, Peisong; Gupta, Shuchi; Sampietro, Sara et al. (2018) RGS10 shapes the hemostatic response to injury through its differential effects on intracellular signaling by platelet agonists. Blood Adv 2:2145-2155
Gupta, Shuchi; Cherpokova, Deya; Spindler, Markus et al. (2018) GPVI signaling is compromised in newly formed platelets after acute thrombocytopenia in mice. Blood 131:1106-1110
Xie, Zhigang; Hur, Seong Kwon; Zhao, Liang et al. (2018) A Golgi Lipid Signaling Pathway Controls Apical Golgi Distribution and Cell Polarity during Neurogenesis. Dev Cell 44:725-740.e4
Zhao, Liang; Thorsheim, Chelsea L; Suzuki, Aae et al. (2017) Phosphatidylinositol transfer protein-? in platelets is inconsequential for thrombosis yet is utilized for tumor metastasis. Nat Commun 8:1216
Kastelowitz, Noah; Tamura, Ryo; Onasoga, Abimbola et al. (2017) Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserine. Sci Rep 7:4275

Showing the most recent 10 out of 290 publications